Thursday, October 18, 2012
Publication and contact
upconversion fluorescent nanoparticles (UCNs) as a photodynamic therapy agent
Mouse studies suggest UCNs
could be photosensitizers that enable photodynamic therapy in deep tissue,
which could be used to help treat cancer. UCNs were synthesized by coating NaYF4-based
nanoparticles with mesoporous silica, resulting in particles that emitted
visible light in response to stimulation with deeper tissue-penetrating
near-infrared light. In a mouse model of melanoma, intratumoral injection of
UCNs conjugated to two photosensitizer dyes followed by near-infrared
irradiation decreased tumor growth compared with intratumoral injection of
vehicle with no irradiation. Next steps include additional preclinical
efficacy studies in small and large animal models of cancer and preclinical
Published online Oct. 18, 2012
Patented; unavailable for
Idris, N.M. et al. Nat.
Med.; published online Sept. 16, 2012;
Contact: Yong Zhang, National University of Singapore, Singapore
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]